This systematic review evaluates established and emerging biochemical markers for diagnosing mitochondrial respiratory chain (MRC) disorders, highlighting the potential of fibroblast growth factor-21 (FGF-21) and oxidative stress indicators. Traditional markers such as lactate and pyruvate remain important, but newer biomarkers may improve diagnostic accuracy. Challenges include a lack of standardized
